article thumbnail

A matter of access

Star OUTiCO

My career started as an RGN, and I continue to work in the NHS in renal medicine. I’ve worked in the pharmaceutical industry full-time for 24 years across a variety of roles but mostly within Leadership and Market Access, and latterly heading up Key Account Management at Boehringer-Ingelheim. So, why Star OUTiCO?

article thumbnail

The Challenge of Growing Pharma Sales

Quantified

In the context of a new medical innovation where there is a high unmet patient need, this means patients are not getting rapid access to medicines that can positively impact or even extend their lives. Prescription medicine companies simply have fewer ways of reaching audiences at scale compared to nearly any other industry.

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How the Ukrainian clinical trial industry is overcoming disruption

Pharmaceutical Technology

Focusing on the law: “Regulators moved quickly to simplify rules across the clinical trial supply chain…the use of public transport to move people, and postal services to move medicinal products around the country has been adopted,” according to Ievgenii Volynets, head of commercial legal at international clinical trial logistics provider Oximio.

article thumbnail

Transforming Oncology Outcomes Through Data & Digital

pharmaphorum

In a recent report from Indegene, 62% of healthcare professionals surveyed said they are “overwhelmed” by product-related promotional content they received from pharmaceutical companies. And according to McKinsey, pharmaceutical companies should consider using “rapidly personalised content” to engage healthcare professionals.

Doctors 57
article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

The need for quality When it comes to injectable medicine, achieving product sterility through aseptic manufacturing is of critical importance. Large-molecule drugs such as biologics are particularly sensitive to foreign contamination and E&L interaction, making these issues key concerns for pharmaceutical companies.

Pharma 52
article thumbnail

Clinical trials in Ukraine: Ensuring supply chain continuity during war

Pharmaceutical Technology

We’re also thinking of a solution for how to transfer medicine and investigational medical products for our clients to the people that need them,” explains Olga Vizgalova, managing director for Ukraine at Oximio. But it doesn’t end there. “We’re Credit: Oximio.

article thumbnail

Selling Effectively In Medical Sales With John Crowder

Evolve Your Success

It’s not about changing the way prescribers practice medicine. Click To Tweet What I will tell you is that changing somebody’s prescribing habits and changing the way they practice medicine are two different skillsets. I’m not going to be able to message you to change the way you manage a patient population.